Does the name Clay Siegall sound familiar to you in anyway? Well, the Clay Siegall of cancer research is well-known throughout this specific industry. This man is simply amazing because he has done so much to better people’s lives. His background in the medical community is top-notch. This guy has attended and has graduated from George Washington University as well as the University of Maryland. While at these two higher-learning facilities, he was able to earn a doctorate as well as earn an undergraduate degree. Zoology and Genetics are his main areas of expertise, and he has used this fine knowledge to build a solid resume.
Dr. Clay Siegall is a lifesaver through and through. This ability to save lives is literally and figuratively. He stands at the front of the pack when it comes to targeted-cancer therapies. On another note, he actually co-founded a startup business back in 1998 and as of today, it is critically acclaimed in cancer research. Seattle Genetics is his company’s name and saving lives at a fast rate is the game. These innovative therapies have a knack for attacking cancer cells much more proficiently than previous cancer therapies. These specific antibody-drug conjugates are highly aggressive in their actions, but they will not cause any harm to the body’s good cells. Yes, this is very correct. At this point, cancer patients won’t necessarily have to worry about the nasty side effects that cancer medications are infamous for delivering.
Drug development is at an all-time high now days and Seattle Genetics is no stranger to achieving this. The company’s stock has drastically increased over the past few years, and the company is worth over $9 billion. Of course, none of this has come by chance. Dr. Clay Siegall has simply laid-out a blueprint to success, and this blueprint has guided the company to its current position.